Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer immunology—analysis of host and tumor factors for personalized medicine
Shuji Ogino, Jérôme Galon, Charles S. Fuchs, et al.
Nature Reviews Clinical Oncology (2011) Vol. 8, Iss. 12, pp. 711-719
Open Access | Times Cited: 275

Showing 1-25 of 275 citing articles:

The immune contexture in human tumours: impact on clinical outcome
Wolf H. Fridman, Franck Pagès, Catherine Sautès‐Fridman, et al.
Nature reviews. Cancer (2012) Vol. 12, Iss. 4, pp. 298-306
Closed Access | Times Cited: 4382
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pagès, Bernhard Mlecnik, Florence Marliot, et al.
The Lancet (2018) Vol. 391, Iss. 10135, pp. 2128-2139
Closed Access | Times Cited: 1742
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo, Mark E. Dudley, Steven A. Rosenberg
Nature reviews. Immunology (2012) Vol. 12, Iss. 4, pp. 269-281
Open Access | Times Cited: 1589
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
Cancer Cell (2014) Vol. 26, Iss. 5, pp. 605-622
Open Access | Times Cited: 1365
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Jérôme Galon, Bernhard Mlecnik, Gabriela Bindea, et al.
The Journal of Pathology (2013) Vol. 232, Iss. 2, pp. 199-209
Open Access | Times Cited: 1257
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik, Gabriela Bindea, Helen K. Angell, et al.
Immunity (2016) Vol. 44, Iss. 3, pp. 698-711
Open Access | Times Cited: 895
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis, Xinmeng Jasmine Mu, Sachet A. Shukla, et al.
Cell Reports (2016) Vol. 15, Iss. 4, pp. 857-865
Open Access | Times Cited: 827
Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
Xiaoyun Liao, Paul Lochhead, Reiko Nishihara, et al.
New England Journal of Medicine (2012) Vol. 367, Iss. 17, pp. 1596-1606
Open Access | Times Cited: 794
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Jérôme Galon, Helen K. Angell, Davide Bedognetti, et al.
Immunity (2013) Vol. 39, Iss. 1, pp. 11-26
Open Access | Times Cited: 790
Targeting natural killer cells and natural killer T cells in cancer
Éric Vivier, Sophie Ugolini, Didier Blaise, et al.
Nature reviews. Immunology (2012) Vol. 12, Iss. 4, pp. 239-252
Open Access | Times Cited: 778
Cancer classification using the Immunoscore: a worldwide task force
Jérôme Galon, Franck Pagès, Francesco M. Marincola, et al.
Journal of Translational Medicine (2012) Vol. 10, Iss. 1
Open Access | Times Cited: 767
Fusobacterium nucleatumand T Cells in Colorectal Carcinoma
Kosuke Mima, Yasutaka Sukawa, Reiko Nishihara, et al.
JAMA Oncology (2015) Vol. 1, Iss. 5, pp. 653-653
Open Access | Times Cited: 570
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
Mai Yamauchi, Teppei Morikawa, Aya Kuchiba, et al.
Gut (2012) Vol. 61, Iss. 6, pp. 847-854
Open Access | Times Cited: 570
The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
Kankana Bardhan, Theodora Anagnostou, Vassiliki A. Boussiotis
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 514
From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
Helen K. Angell, Jérôme Galon
Current Opinion in Immunology (2013) Vol. 25, Iss. 2, pp. 261-267
Closed Access | Times Cited: 509
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Peng Jin, Junzo Hamanishi, Noriomi Matsumura, et al.
Cancer Research (2015) Vol. 75, Iss. 23, pp. 5034-5045
Open Access | Times Cited: 472
The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer
Sofia Edin, Maria L. Wikberg, Anna M. Dahlin, et al.
PLoS ONE (2012) Vol. 7, Iss. 10, pp. e47045-e47045
Open Access | Times Cited: 458
Exploiting the curative potential of adoptive T‐cell therapy for cancer
Christian S. Hinrichs, Steven A. Rosenberg
Immunological Reviews (2013) Vol. 257, Iss. 1, pp. 56-71
Open Access | Times Cited: 449
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
Ronald J. deLeeuw, Sara E. Kost, Juzer Kakal, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 11, pp. 3022-3029
Open Access | Times Cited: 425
Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
Paul Lochhead, Aya Kuchiba, Yu Imamura, et al.
JNCI Journal of the National Cancer Institute (2013) Vol. 105, Iss. 15, pp. 1151-1156
Open Access | Times Cited: 418
Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers
Giuseppe Di, Francesca Bergomas, Fabio Grizzi, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 8, pp. 2147-2158
Open Access | Times Cited: 318
Association ofFusobacterium nucleatumwith immunity and molecular alterations in colorectal cancer
Katsuhiko Nosho
World Journal of Gastroenterology (2016) Vol. 22, Iss. 2, pp. 557-557
Open Access | Times Cited: 312
What is personalized medicine: sharpening a vague term based on a systematic literature review
Sebastian Schleidgen, Corinna Klingler, Teresa Bertram, et al.
BMC Medical Ethics (2013) Vol. 14, Iss. 1
Open Access | Times Cited: 290
Biomimetic Nanotechnology toward Personalized Vaccines
Jiarong Zhou, Ashley V. Kroll, Maya Holay, et al.
Advanced Materials (2019) Vol. 32, Iss. 13
Open Access | Times Cited: 288
Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
Shuji Ogino, Kaori Shima, Jeffrey A. Meyerhardt, et al.
Clinical Cancer Research (2011) Vol. 18, Iss. 3, pp. 890-900
Open Access | Times Cited: 257
Page 1 - Next Page

Scroll to top